BioSyent inches higher, resistance at 12-day EMA February 28, 2017 17:00 EST
CANADIAN DAILY STOCK REPORT
BioSyent Inc. (TSXV:RX), Canada's 3rd largest Drug manufacturers company by market cap, has increased 1.3% but fell short of the 12-day Exponential Moving Average [EMA] of CAD7.32. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price increase was 1.8%. The volume was 0.5 times the average daily trading volume of 20,102 shares. The stock last traded at CAD7.20.
BIOSYENT BULLISH SIGNALS